Analysis finds ties between pharmaceutical industry and federal government are deepening; Mississippi readies a Medicaid work requirement waiver; research identifies danger of interactions between herbal supplements and prescription medications.
An analysis from Kaiser Health News found that the ties between the pharmaceutical industry and the federal government are deepening. Alex Azar, the newly confirmed HHS secretary, is just the latest example of the so-called “revolving door” connecting the federal government and the drug industry. There are more than 300 former congressional staffers who work for pharma companies or a pharma lobbying firm and nearly a dozen former employees of the drug industry now work for the government.
Although Medicaid beneficiaries in Kentucky just sued the government over new work requirements to receive benefits, Mississippi is preparing its own waiver request to implement the same restriction. According to The Hill, the state is seeking a 5-year waiver to require able-bodied adults to participate in at least 20 hours of workforce training every week. If beneficiaries aren’t participating in approved activities, such as working, volunteering, or enrolled in a drug treatment program, they will be kicked off Medicaid. Mississippi’s waiver request differs from Kentucky, which had expanded Medicaid and targeted its requirements at those newly eligible beneficiaries.
New research has found that mixing common herbal supplements with prescription medications can result in dangerous interactions. TIME reported that the challenge is that people often don’t tell their healthcare providers what over-the-counter drugs and supplements they take. Herbals supplements can result in medications being less effective. The research found that of 49 cases of adverse drug reactions reviewed, herb—drug interactions were probable for 51%.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Senate Questions NIH Nominee on Funding, Transparency, and COVID-19 Impact
March 5th 2025Jay Bhattacharya, MD, PhD, defended his vision for the National Institutes of Health in a Senate committee confirmation hearing, tackling concerns on research funding, public trust, and scientific integrity.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Trump’s Immigration Crackdown Fuels Health Crisis: Detention, Depression, Deportation, and Disease
March 5th 2025Strict changes to immigration policies nationwide create a public health crisis in overcrowded detention centers, draining taxpayer dollars and diminishing undocumented immigrants' contributions to subsidies.
Read More